Business · 04/03/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting to Discuss COVID-19 Vaccine Strain Selection
Summary
The FDA is hosting a public meeting of the Vaccines and Related Biological Products Advisory Committee to select strains for the 2024-2025 COVID-19 vaccine formula, with public comments invited.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →